4.5 Article

DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 19, Issue 11, Pages 1093-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2394

Keywords

-

Funding

  1. Division of Signal Transduction Therapy Unit
  2. AstraZeneca
  3. Boehringer-Ingelheim
  4. GlaxoSmithKline
  5. Merck KgaA
  6. Janssen Pharmaceutica
  7. Pfizer
  8. Medical Research Council Protein Phosphorylation Unit
  9. Medical Research Council UK
  10. Association for International Cancer Research
  11. Cancer Research UK
  12. Cancer Research UK [11243] Funding Source: researchfish
  13. Medical Research Council [MC_U127070192] Funding Source: researchfish
  14. MRC [MC_U127070192] Funding Source: UKRI

Ask authors/readers for more resources

Ubiquitin-binding domains (UBDs) are crucial for recruiting many proteins to sites of DNA damage. Here we characterize C1orf124 (Spartan; referred to as DVC1), which has an UBZ4-type UBD found predominantly in DNA repair proteins. DVC1 associates with DNA replication factories and localizes to sites of DNA damage in human cells, in a manner that requires the ability of the DVC1 UBZ domain to bind to ubiquitin polymers in vitro and a conserved PCNA-interacting motif. DVC1 interacts with the p97 protein 'segregase'. We show that DVC1 recruits p97 to sites of DNA damage, where we propose that p97 facilitates the extraction of the translesion synthesis (TLS) polymerase (Pol) eta during DNA repair to prevent excessive TLS and limit the incidence of mutations induced by DNA damage. We introduce DVC1 as a regulator of cellular responses to DNA damage that prevents mutations when DNA damage occurs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available